Faculty Information - Shoko Tsuji

（Last updated : 2026-04-28 14:41:55）

Shoko Tsuji
Department Kawasaki Medical School Kawasaki Medical School, Department of Rheumatology,

Position Instructor

■ Journal

1.	2025/06/04	NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors
2.	2025/02/26	Clinical Significance of Antinuclear Antibodies in Patients with　Rheumatoid Arthritis: From SETOUCHI-RA Registry
3.	2021/04/17	SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus.
4.	2021/03	In vivo analysis of thrombus formation in arthritic mice.
5.	2020/06/10	Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis
6.	2019/08	Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome
7.	2019/05	Infection of Helicobacter cinaedi Should be Treated for an Adequate Duration with Combined Antibiotic Therapy: Author's Reply.
8.	2019/04	Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Fas^lpr Mice.
9.	2018/12	Bacteremia possibly caused by Helicobacter cinaedi and associated with painful erythema in rheumatoid arthritis with malignant lymphoma
10.	2018/06	Scrub typhus (Tsutsugamushi disease) in a patient presenting with hemophagocytic syndrome
11.	2018/01	Mycophenolate mofetil treatment in a patient with recurrent lymphocytic hypophysitis.
12.	2018/01	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
13.	2017/12	Nivolumab-induced polyarthritis
14.	2017/09	Successful treatment using rituximab in a patient with refractory polymyositis complicated by scleroderma renal crisis
15.	2017/08	POEMS syndrome in a patient with rheumatoid arthritis
16.	2015/12	Arthritis in a patient with Takayasu arteritis
Display 5 items
Display all(16)

■ Presentation

1.	2026/04/23	Baseline IgM/IgG Ratio as a Biomarker for Effectiveness of Rituximab in Systemic Sclerosis-Related Interstitial Lung Disease （Speech，General）
2.	2026/04/23	Clinical Characteristics and Risk Factors for Persistent D2TRA～Findings from the SETOUCHI-RA Registry～（Speech，General）
3.	2026/04/23	Risk Factors for Early Discontinuation of Avacopan in Patients with ANCA-Associated Vasculitis （Speech，General）
4.	2021/04/26	Excessive Angiotensin II exacerbates bone erosion in a murine tumor necrosis factor-mediated arthritis model （Speech）
5.	2020/12/04	The role of an adaptor protein SH3BP2 in the pathogenesis of systemic lupus erythematosus （Poster notice，General）
6.	2020/11/07	SH3BP2 Deciency Ameliorates Murine Systemic Lupus Erythematosus （Poster notice，General）
7.	2020/10/24	Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis （Poster notice，General）
8.	2020/10/24	SH3BP2 deficiency ameliorates murine systemic lupus erythematosus （Poster notice，General）
9.	2020/07/08	全身性エリテマトーデスモデルマウスにおけるアダプター蛋白SH3BP2 の自己免疫現象における役割の解明（Poster notice，General）
10.	2019/11/10	The role of adopter protein SH3BP2 in a murine systemic lupus erythematosus model （Poster notice，General）
11.	2019/11/10	The Study of the Novel G87V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS) （Poster notice，General）
12.	2019/04/17	SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice （Speech，General）
13.	2019/04/16	The Study of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome(TRAPS) （Speech，General）
14.	2019/04/15	In vivo imaging of arterial thrombus formation in a murine arthritis model （Speech，General）
15.	2018/10/21	The novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome (TRAPS) decreases the cell surface expression of TNFR1 （Poster notice，General）
16.	2018/04/27	Bone systemic administration of angiotensin II and its type 1 receptor gene deletion exacerbates erosive bone destruction in hTNF-transgenic arthritis mice （Speech，General）
17.	2018/04/27	Myostatin inhibition reduces bone loss in an unloading osteoporosis model （Speech，General）
18.	2018/04/27	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastgenesis （Speech，General）
19.	2018/04/27	SH3BP2 gain-of-function mutation alleviates lupus phenotypes in B6.MRL-Faslpr mice （Speech，General）
20.	2018/04/26	Functional analysis of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF receptor-associated periodic syndrome(TRAPS) （Speech，General）
21.	2017/11/07	SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice （Poster notice，General）
22.	2017/11/06	Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction ofhTNF-Transgenic Arthritis Mice （Poster notice，General）
23.	2017/11/05	Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS) （Poster notice，General）
24.	2017/11/05	Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2 （Poster notice，General）
25.	2017/11/05	The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models （Poster notice，General）
26.	2017/09/18	Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2 （Poster notice，General）
27.	2017/04/21	Tankyrase regulates bone mass and osteoclastogenesis （Speech，General）
28.	2017/04/20	Angiotensin II exacerbates bone destruction in human TNF-transgenic arthritis mice （Speech，General）
29.	2017/04/20	The effect of myostatin inhibition on bone loss in murine osteoporosis models （Poster notice，General）
30.	2016/11/14	Tankyrase Regulates Osteoclastogenesis Via SH3BP2 （Poster notice，General）
Display 5 items
Display all(30)